Ann: Investor Presentation, page-6

I have the same query regarding the eyelash too. Management seem to impede on this product, was it because fgf5 was far lesser for eyelash render the fgf5 based product useless?? Better to make sure the product works, or we able to quantify the result. If not, it will be a big problem if the new product found out to be bogus, the reputation will have impact on other products too.

If eyelasher works, quickly bring it out.

Will there be any more CR? Our almost 8 million cash piles (-1M on ikon; -1M on debt repayment) can last for how long??

Ulta, do we have plan to sell there? Did Eck help up negotiating the price for listing the product there?

Ultimately, when can we expect cash flow positive? This will be the ONLY factor to drive share price, nothing else.